|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 236.85 DKK | -1.58% |
|
+0.74% | -27.18% |
| 10:03am | SKAGEN Vekst slips 2.47 percent in March - new positions initiated in Easyjet, Elkem and Vestas | FW |
| 04-10 | Wall Street Gets a CPI Lifeline |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 168B | |||||
| 841B | |||||
| 574B | |||||
| 368B | |||||
| 320B | - | ||||
| 318B |
- Stock Market
- Equities
- NOVO B Stock
- Charts Novo Nordisk A/S
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition